EEI also attenuates NASH, which is a progressive form of NAFLD, by reducing lipid accumulation, fatty change, inflammation and increase of AST and ALT enzymes in the liver of rats. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.